MD Anderson Cancer Center

See the following -

Case Study: MD Anderson Successfully Implements Tools to Migrate Clinical Research Data from MUMPS to Oracle

The University of Texas MD Anderson Cancer Center has successfully completed the initial stages of a major migration of their MUMPS-based Clinical Trials Databases to Oracle as one of the critical stages in MD Anderson’s multiyear eResearch project to modernize management of Clinical Trials. The MD Anderson Cancer Center chose CAV Systems' Evolve Suite to carry out the migration. The institutions have produced a case study outlining the background and results of this extraordinary project. Read More »

CAV Systems Announces Relational Database Replicator for FileMan MUMPS Databases

Press Release | CAV Systems | November 6, 2014

CAV Systems Ltd, a leading Israeli software company, recently completed development of FileMan Replicator, a software solution that creates and continuously updates a relational database replica of MUMPS databases, either Caché or GT.M,  that are managed by the FileMan Database Management System. Read More »

Enhancements Minimize Data Latency at MD Anderson Cancer Center Data Vault

Press Release | CAV Systems LTD | June 16, 2014

CAV Systems Ltd...has recently completed a major enhancement of Evolve Suite – the company’s “relational from MUMPS” data mapping and migration tools – for The University of Texas MD Anderson Cancer Center, Office of Protocol Research (OPR). Prior to the enhancements, even with the benefits of the Evolve Data Migrator, the transfer of data from the PDMS system sitting on a legacy VAX/VMS platform to the Data Vault was a lengthy process involving multiple platforms. With the completion of the enhancements, the “freshness” of the Clinical Trials data in the Data Vault is now determined by the needs of the users of the Data Vault rather than the operational constraints of the multi-platform data extraction process.

Read More »

Experts Say IBM Watson’s Flaws are Rooted in Data Collection and Interoperability

Evan Sweeney | Fierce Healthcare | September 6, 2017

Despite being backed by a significant budget and the marketing power of a major technology company, IBM Watson appears to be falling short of expectations when it comes to revolutionizing cancer care. The shortcomings of IBM’s premier artificial intelligence system—made famous by its appearance on Jeopardy in 2011 and later co-pted to provide support for oncologists—are linked to a number of factors, according to an in-depth investigation by Stat that included interviews with doctors and artificial intelligence experts from around the world...

Read More »

IBM Pitched Its Watson Supercomputer as a Revolution in Cancer Care. It’s Nowhere Close

Casey Ross | STAT | September 5, 2017

It was an audacious undertaking, even for one of the most storied American companies: With a single machine, IBM would tackle humanity’s most vexing diseases and revolutionize medicine. Breathlessly promoting its signature brand — Watson — IBM sought to capture the world’s imagination, and it quickly zeroed in on a high-profile target: cancer. But three years after IBM began selling Watson to recommend the best cancer treatments to doctors around the world, a STAT investigation has found that the supercomputer isn’t living up to the lofty expectations IBM created for it. It is still struggling with the basic step of learning about different forms of cancer...

Read More »

Java from MUMPS (JUMPS) used in data migration project for Clinical Trials Project

Press Release | CAV Systems | May 22, 2012

CAV Systems Ltd, a leading Israeli software company has been selected by The University of Texas MD Anderson Cancer Center to map and migrate the Clinical Trials Databases managed by the Office of Protocol Research (OPR) from the current MUMPS system to Oracle as one of the critical stages in MD Anderson’s multiyear eResearch project to modernize management of Clinical Trials. With more than 4,000 clinical studies being administered annually, the current in-house developed system – the Protocol Data Management System (PDMS) – is being phased out and replaced by commercial software products.

Read More »

Obama and Biden Blast EHR Vendors for Data Blocking

As they are winding their terms in office, President Barack Obama and Vice President Joe Biden dropped a stink bomb on the health IT industry. Speaking at different events on Friday, January 9th, the President and Vice President both criticized proprietary electronic health record (EHR) vendors as the primary obstacle to the success of their administration’s health care strategy. This is the highest level acknowledgement so far of the serious impact that “lock-in” EHR software vendors are having on America’s medical infrastructure and the ability of physicians to provide medical care.

Read More »

Photonics-led Consortium Leverages $3B in Private Cancer Research for Early Detection Technologies

Press Release | National Photonics Initiative | June 29, 2016

The National Photonics Initiative (NPI)...today unveiled a white paper and cancer technology road map that identifies the most promising existing and new technologies for increased and concerted private and public investment to achieve the goals of the National Cancer Moonshot – accelerate the early detection of cancer and save lives. 

Read More »

VHA Joins 'OpenNotes' Effort for EHR & PHR Systems

The Veterans Health Administration (VHA) has joined the Robert Wood Johnson (RWJ) Foundation's 'OpenNotes' initiative as a partner along with other healthcare provider organizations – Beth Israel Deaconess Medical Center, Harborview Medical Center, Geisinger Health System, MD Anderson Cancer Center . These organizations are all fully committed to giving patients online access to clinical notes. Read More »